Narendranath Epperla

112PUBLICATIONS
408CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (112)

|Sep 24, 2026
Risk factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas.

|Jul 25, 2026
Cardiovascular Toxicity Associated With Bispecific Antibodies in Hematological Malignancies: A Comprehensive Pharmacovigilance Analysis.

|Jul 23, 2026
Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models.

|Jul 14, 2026
Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.

|Jul 08, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CART.

|Jun 09, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

Pageof 19

Frequent Collaborators

22 joint publications

Reem Karmali

15 joint publications

Timothy Voorhees

14 joint publications

Mehdi Hamadani

14 joint publications

Natalie S Grover